Nahdi Medical Company · TADAWUL:4164
Nahdi Medical — Q1 2026 Earnings Presentation
19 slides from Nahdi Medical's earnings presentation, 2026
Slide 1: Nahdi Medical Company Investor Presentation Q1 2026
INVESTOR PRESENTATION Nahdi Medical Company Q1 2026
Slide 2: Financial Highlights
Financial Highlights
Slide 3: Q1 2026 Financial Highlights
Q1 2026 Financial Highlights (% of revenue) Q1 2026 % Change Q1 2025 Revenue 2.79B 6.1% 2.64B RESILIENT FINANCIAL Gross Profit 988M(35.3%) 4.7% 944M (35.8%) PERFORMANCE Operating Profit 260M(9.3%) -3.8% 270M (10.2%) Net Profit 236M (8.4%) -7.6% 255M (9.7%) EBITDA 461M (16.5%) 0.1% 461M (17.5%) STRON
Slide 4: Solid Revenue Growth Across Businesses & Categories
Solid Revenue Growth Across Businesses & Categories Pharmacies 1,181 1,222 1,202 1,223 Revenue grew by 6.1 % YoY in Q1 2026, increasing by 160 million, Clinics 10 14 11 14 driven by strong growth momentum across all business segments M Retail business rose by 4.7% fueled 9,446 10,213 by continued gr
Slide 5: Diversified Sales Channel Growth Driving Top-Line Acceleration
Diversified Sales Channel Growth Driving Top- Line Acceleration 3,000 M 27 14 2,794 117 2,635 +4.7% +34.8% +31.8% +6.1% 2,500 The Retail business continued to lead the overall growth 2,000 Contribution from Healthcare and Regional expansion business increased to 6% up 1,500 95% 94% from 5% same peri
Slide 6: Best in Class Operating Profit Margin
Best in Class Operating Profit Margin Operating profit impacted by Operating Margin 9.2% 9.1% 10.2% 9.3% continued investments to support revenue growth The gross profit increased by 4.7%, while gross margin stood at 35.3% M reflecting the change in business mix with the accelerated growth in 873 92
Slide 7: Attractive Net Profit Profile
Net Profit/ Revenue Attractive Net Profit Profile 8.7% 8.1% 9.7% 8.4% Net profit landed at 236 million, reflecting an 8.4% margin Overall, the Company’s net profit M growth remained almost flat compared to the same period last year, while the 821 831 year-on-year comparison reflects a decline of 7.6
Slide 8: 2026 Guidance
Guidance 2026 Guidance Total revenue Growth 6% - 8% EPS Growth 1% - 2% Capex ~4% Dividend Policy 75% - 85% Note: 2026 guidance is for full fiscal year excluding the impact Regional developments
Slide 9: Strategy & Operational Review
Strategy & Operational Review
Slide 10: Our Passion for People
Our Passion for People Always Delivers Value to Our Guests 39 % Nationalization No. 1 • 1,400+ national pharmacists • Reached 16.5% feminization • ~200K hours of training conducted in Q1. Nahdi Medical Company | Q1 2026 EARNINGS CALL
Slide 11: Guest Satisfaction - the Cornerstone of our strategy
Nahdi: Guest Satisfaction - the Cornerstone of our strategy Stronger Brand Equity YoY Nielsen Store Equity Index ** 68.1% of revenue Q1 2025 Q1 2026 generated from Nahdi “Nuhdeek” Guests * As Q1 2026 7 6.9 Strong 3.4 3.4 89 NPS As Q1 2026 1.2 1.3 Moderate 0.9 0.9 0.7 0.7 0.3 0.3 Weak Source: Company
Slide 12: Strategic Initiatives
Strategic Initiatives
Slide 13: Market Challenges & Strategic Response
Market Challenges & Strategic Response KEY MARKET CHALLENGES MITIGATION STRATEGY & ACTIONS Softening Market Demand Guest-Centric Growth Strategy Driven by evolving shopper behavior and Strengthening guest engagement and loyalty, more cautious spending patterns delivering +150 bps market share gain C
Slide 14: Digital Acceleration: Seamless Experiences to Fuel Nahdi's Growth
Digital Acceleration: Seamless Experiences to Fuel Nahdi’s Growth 30.7% Online contribution 25.8% 21.7% 16% 13% 22 23 24 25 Q1-26 New Record 1M orders during Ramadan season
Slide 15: Serve our Community with Purpose
Serve our Community with Purpose 89 ~ 10% NPS Cross selling 22% 42.6 K 34.8 K Q4 2025 Q1 2026 Avg daily transactions / working day
Slide 16: Nahdi's Private Label Powerhouse
Nahdi’s Private Label Powerhouse; Delivering Growth & Guest Loyalty 18.4% 17% 13% 13% 12.50% Private Label contribution 2022 2023 2024 2025 Q1 2026
Slide 17: Nahdi's Leap: Advancing National Healthcare Leadership
Nahdi’s Leap: Advancing National Healthcare Leadership Revenue growth momentum 350 M 200 VS 101 78 105 49 2022 2023 2024 2025 Q1 2025 Q1 2026 Guests visits growth M 2.00 1.40 13% 1.00 VS 0.49 0.48 0.55 2022 2023 2024 2025 Q1 2025 Q1 2026
Slide 18: We exist to add beats to the lives of our guests
We exist to add beats to the lives of our GUESTS Nahdi Medical Company 19
Slide 19: Thank You
Thank You Investor Relations Department Contacts: Website: https://investors.nahdi.sa/ Email: IR@nahdi.sa Phone: +966 556 315 822 Nahdi Medical Company 20
Nahdi Medical Company — Q1 2026 Earnings Presentation on 6ix